logo

ASTEC vs RALLIS: Stock Comparison

ASTEC LIFESCIENCES vs RALLIS INDIAUpdated 23 Oct 26, 4:08 PM ISTNSE & company filings

RALLIS INDIA is the larger company by market capitalisation. ASTEC LIFESCIENCES shows faster revenue growth, while RALLIS INDIA shows a higher ROE, a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

ASTEC leads 1; RALLIS leads 8 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

ASTECRALLIS

Valuation lens

What price are you paying?

Market CapContext only
₹1,482 Cr
₹3,774 Cr
P/E RatioSame reading
0x
0x
P/B RatioRALLIS has the lower reading
3.79x
0x ✓
EPSRALLIS has the higher reading
₹-8.4
₹-0.73 ✓
Book ValueContext only
₹175.43
₹105.06
Dividend YieldRALLIS has the higher reading
0%
1.55% ✓

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
RALLIS is the larger company
₹3,774 Cr vs ₹1,482 Cr
P/B Ratio
RALLIS has a lower P/B
0x vs 3.79x
EPS
RALLIS has higher earnings per share
₹-0.73 vs ₹-8.4
Dividend Yield
RALLIS has a higher dividend yield
1.55% vs 0%
Revenue Growth (TTM YoY)
ASTEC has faster revenue growth
32.7% vs 6%
ROE
RALLIS has a higher ROE
9.01% vs -20.78%
ROCE
RALLIS has a higher ROCE
12.93% vs -5.62%
Net Margin
RALLIS has a higher net margin
2.03% vs -14.69%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricASTECRALLIS
SectorChemicalsChemicals
IndustryPesticides & AgrochemicalsPesticides & Agrochemicals

Price

MetricASTECRALLIS
Live Price₹663.7₹194.57
Day Change-0.82%-4.44%
Volume33,48420.36 L
52-Week High₹941.75₹298.4
52-Week Low₹513.4₹193.4
Distance from 52W High-29.52%-34.8%

Valuation

MetricASTECRALLIS
Market Cap₹1,482 Cr₹3,774 Cr
P/E Ratio0x0x
P/B Ratio3.79x0x
EPS₹-8.4₹-0.73
Book Value₹175.43₹105.06
Dividend Yield0%1.55%

Growth

MetricASTECRALLIS
Revenue Growth (TTM YoY)32.7%6%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricASTECRALLIS
ROE-20.78%9.01%
ROCE-5.62%12.93%
Net Margin-14.69%2.03%
Operating Margin-10.4%8.97%
Debt to Equity1.15x0x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricASTECRALLIS
Promoter Holding71.96%55.08%
FII Holding0.03%▲ 0.02 pp6.08%▼ 3.04 pp
DII Holding3.34%▲ 0.01 pp10.63%▼ 1.09 pp
Public Holding24.67%▼ 0.02 pp27.79%▲ 4.12 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ASTEC LIFESCIENCES and RALLIS INDIA.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.